Measuring tumor response in the anti-PD1 / anti-PDL1 era and correcting for pseudoprogression

Date 04 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Beyond RECIST: Novel approaches for evaluating tumor response to molecular targeted agents
Topics Immunotherapy
Therapy
Presenter Mario Sznol